ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Coronavirus

Pakistan approves China Sinopharm COVID vaccine for emergency use

Authorization will be reviewed quarterly for safety, efficacy and quality

The announcement comes two days after AstraZeneca's vaccine developed with Oxford University received a similar authorization in Pakistan.    © Reuters

ISLAMABAD (Reuters) -- Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said, two days after AstraZeneca's vaccine developed with Oxford University received a similar authorization.

The Drug Regulatory Authority Pakistan (DRAP) said the vaccine, manufactured by China National Pharmaceutical Group (SinoPharm), had been given emergency use approval (EUA).

Pakistan's health ministry has said the country was in process of speaking to different vaccine makers.

"The two COVID-19 vaccines have been granted EUA with certain conditions," a DRAP's spokesman said, adding that both vaccines have been evaluated for their safety and quality.

The authorization will be reviewed on quarterly basis for further data regarding safety, efficacy and quality, the spokesman said.

Pakistan has been engaging with a number of vaccine makers, health minister Faisal Sultan said over the weekend, adding that the country could get "in the range of tens of millions" of vaccine doses under an agreement with China's Cansino Biologics Inc.

The vaccine company's Ad5-nCoV COVID-19 candidate is nearing completion of Phase III clinical trials in Pakistan. The preliminary results of the Cansino vaccine may come in by mid-February, Sultan said.

However, Pakistan has yet to place an order to procure any vaccine.

The minister said Pakistan planned to cover vaccines for the majority of the population for free, adding that private companies could also be allowed to import and sell vaccines once supply was available to an authorized company.

Pakistan reported 1,920 new coronavirus infections and 46 deaths on Monday, taking the total number of cases to more than 521,212 with fatalities approaching 11,000.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more